PHARYNGEAL CHLAMYDIA INFECTION

This adverse event was reported 7 times

PHARYNGEAL CHLAMYDIA INFECTION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 INFLIXIMAB-DYYB 1 0.0003
1 EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 3 0.0003
2 ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE 2 0.0002
3 GENTAMICIN SULFATE 2 0.0001
4 ATOVAQUONE 1 0.0001
5 DOLUTEGRAVIR SODIUM 1 0.0001
6 DESLORATADINE 1 0.0001
7 THEOPHYLLINE ANHYDROUS 1 0.0001
8 LEVOCETIRIZINE DIHYDROCHLORIDE 1 0.0000
9 AMOXICILLIN 1 0.0000
See all drugs enriched for association with PHARYNGEAL CHLAMYDIA INFECTION